Group Belderbos

Medicijnen en Levenswetenschappen

1. Leukemia 100%
2. Heterografts 98%
3. Clone Cells 81%
4. Hematopoietic Stem Cells 80%
5. Graft vs Host Disease 54%
6. Cell Transplantation 52%
7. Fetal Blood 51%
8. Acute Myeloid Leukemia 49%
9. Human Adenovirus Infections 44%
10. Hematopoiesis 42%
11. Allogeneic Cells 41%
12. CRISPR-Associated Protein 9 40%
13. Pediatrics 39%
14. Intracranial Hypotension 39%
15. T-Lymphocytes 35%
16. Human Adenoviruses 34%
17. Tissue Donors 32%
18. Gene Editing 31%
19. Cytoprotection 30%
20. Clustered Regularly Interspaced Short Palindromic Repeats 29%
21. Bone Marrow 29%
22. Mutation 28%
23. Posture 25%
24. Immunotherapy 25%
25. Organoids 25%
26. Precursor Cell Lymphoblastic Leukemia-Lymphoma 25%
27. Data Analysis 24%
28. Natural Killer Cells 24%
29. HLA-Bw4 antigen 23%
30. Dendritic Cells 23%
31. Headache 22%
32. Hematopoietic Stem Cell Transplantation 21%
33. Publications 21%
34. Neutrophils 20%
35. Drug Therapy 17%
36. Survival 14%
37. Mortality 11%
38. Child 11%
39. Therapeutics 10%
40. Cell Differentiation 10%
41. Transplantation Conditioning 10%
42. Epidural Blood Patch 10%
43. Phenotype 9%
44. Stem Cells 9%
45. Methotrexate 9%
46. Cell- and Tissue-Based Therapy 9%
47. Natural Killer Cell Receptors 8%
48. Blood Cells 8%
49. Immunogenetics 8%
50. HLA-B Antigens 8%
51. Chimerism 8%
52. Bed Rest 8%
53. HLA-A Antigens 8%
54. Spinal Puncture 7%
55. Cell Count 7%
56. Blood Donors 7%
57. Neoplasms 7%
58. Viremia 7%
59. Bone Marrow Cells 7%
60. Vincristine 6%
61. Immunocompromised Host 6%
62. Caffeine 6%
63. Patient Care 6%
64. Chromatin 6%
65. Dexamethasone 5%
66. Noise 5%
67. Morbidity 5%
68. Libraries 5%
69. Transcription Factors 5%
70. Transfection 5%
71. Regeneration 5%
72. Transplantation 5%